GGrantIndex
← Leaderboards

Razvan Liviu Cornea

University Of California At Davis

$5,258,186
Attributed
$11,536,414
Total exposure
4
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.8M · FY201422
$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$11,536,414 · 4

By mechanism

R01$11,036,971 · 3
R43$499,443 · 1

Top collaborators

Most similar at University Of California At Davis

Same institution · by research overlap

Others in their field

Top investigators on “Heart

Research focus

HeartFluorescenceSarcoplasmic ReticulumFluorescence Resonance Energy TransferCalciumStructureHeart FailureMuscle CellsMolecularArrhythmiaCardiacInsightPeptidesVesicleTacrolimus Binding ProteinsCalmodulinTherapeutic TargetBaseRyanodine Receptor Calcium Release ChannelPathologicPathologyDantroleneHigh Throughput ScreeningAmerican

Grant awards (16)

Structural Dynamics of Cardiac Muscle Calcium ATPase Regulation$773,075
R01 · FY2022 · HL
Calmodulin-dependent regulation of cardiac ryanodine receptor$760,168
R01 · FY2022 · HL
Structural Dynamics of Cardiac Muscle Calcium ATPase Regulation$772,367
R01 · FY2021 · HL
Calmodulin-dependent regulation of cardiac ryanodine receptor$760,168
R01 · FY2021 · HL
High-Throughput Screens to Discover Novel Inhibitors of Leaky RyR2 for Heart Failure Therapy$754,179
R01 · FY2021 · HL · contact PI
Drug Discovery Pipeline Targeting Pathologically Leaky Calcium Release Channels in Age-Related Indications$499,443
R43 · FY2021 · AG
Structural Dynamics of Cardiac Muscle Calcium ATPase Regulation$782,326
R01 · FY2020 · HL
Calmodulin-dependent regulation of cardiac ryanodine receptor$760,168
R01 · FY2020 · HL
High-Throughput Screens to Discover Novel Inhibitors of Leaky RyR2 for Heart Failure Therapy$757,332
R01 · FY2020 · HL · contact PI
Calmodulin-dependent regulation of cardiac ryanodine receptor$774,418
R01 · FY2019 · HL
High-Throughput Screens to Discover Novel Inhibitors of Leaky RyR2 for Heart Failure Therapy$760,410
R01 · FY2019 · HL · contact PI
High-Throughput Screens to Discover Novel Inhibitors of Leaky RyR2 for Heart Failure Therapy$788,203
R01 · FY2018 · HL · contact PI
Pathophysiological Regulation of Cardiac Myocyte RyR Channel$649,140
R01 · FY2017 · HL
Pathophysiological Regulation of Cardiac Myocyte RyR Channel$649,140
R01 · FY2016 · HL
Pathophysiological Regulation of Cardiac Myocyte RyR Channel$637,565
R01 · FY2015 · HL
Pathophysiological Regulation of Cardiac Myocyte RyR Channel$658,312
R01 · FY2014 · HL